Articles From: NewLead Holdings Ltd. Announces Acquisition of One Newbuilding Dry Bulk Vessel to Newman Ferrara LLP Announces Investigation of DFC Global Corp.


PIRAEUS, Greece , Dec.
Sign-up for NewLead Holdings Ltd. Announces Acquisition of One Newbuilding Dry Bulk Vessel investment picks
2014/3/14
PIRAEUS, Greece , March 14, 2014 /PRNewswire/ -- NewLead Holdings Ltd.
Sign-up for NewLead Holdings Ltd. Announces Agreements to Acquire Two Eco-Type 2012-Built Handysize Vessels investment picks
PIRAEUS, Greece , Dec.
Sign-up for NewLead Holdings Ltd. Announces Completion of Acquisition of Coal Wash Plant in Kentucky, USA investment picks
2014/3/10
PIRAEUS, Greece , March 10, 2014 /PRNewswire/ -- NewLead Holdings Ltd.
Sign-up for NewLead Holdings Ltd. Announces Placement of $25.0 Million Perpetual Preferred Equity investment picks
PIRAEUS, Greece , Sept.
Sign-up for NewLead Holdings Ltd. Announces Revision to September 18, 2013 Announcement investment picks
PIRAEUS, Greece , Oct.
Sign-up for NewLead Holdings Ltd. Announces Revisions to September 18, 2013 Announcement investment picks
2014/2/13
PIRAEUS, Greece , Feb.
Sign-up for NewLead Holdings Ltd. Announces Signing of Term Sheet for 75% Financing for Two Eco-type Handysize Dry Bulk Vessels investment picks
2013/8/8
PIRAEUS, Greece , Aug.
Sign-up for NewLead Holdings Ltd. Receives NASDAQ Acceptance of its Plan to Regain Compliance investment picks
PIRAEUS, Greece , Dec.
Sign-up for NewLead Holdings Ltd. Receives NASDAQ Notification Related to Market Value of Listed Securities investment picks
2013/10/4
PIRAEUS, Greece , Oct.
Sign-up for NewLead Holdings Ltd. Receives NASDAQ Notification Related to Minimum Bid Price investment picks
2014/1/6
PIRAEUS, Greece , Jan.
Sign-up for NewLead Holdings Ltd. Regains Compliance with NASDAQ Minimum Bid Price Requirement investment picks
2014/2/26
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1093198&ProfileId=051205&sourceType=1 AMES, IA --
Sign-up for NewLink Genetics Appoints Eugene P. Kennedy, M.D., as Vice President for Clinical and Medical Affairs investment picks
2014/3/11
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1096875&ProfileId=051205&sourceType=1 AMES, IA --
Sign-up for NewLink Genetics Corporation Reports Fourth Quarter and Year End 2013 Financial Results investment picks
2013/8/7
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1040474&ProfileId=051205&sourceType=1 AMES, IA --
Sign-up for NewLink Genetics Corporation Reports Second Quarter 2013 Financial Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1048268&ProfileId=051205&sourceType=1 AMES, IA --
Sign-up for NewLink Genetics to Present at September Financial Conferences investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1066063&ProfileId=051205&sourceType=1 AMES, IA --
Sign-up for NewLink Genetics to Present at the Credit Suisse 2013 Healthcare Conference investment picks
2014/3/25
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1100723&ProfileId=051205&sourceType=1 AMES, IA --
Sign-up for NewLink Genetics to Present Data at the AACR 2014 Annual Meeting investment picks
2014/2/10
Nuveen Investments, a leading global provider of investment services to institutions as well as individual investors, today announced that the Nuveen Pennsylvania Investment Quality Municipal Fund (NYSE: NQP) has declared additional, post-merger distributions.
Sign-up for Newly Merged Nuveen Closed-End Funds Declare Post-Merger Distributions investment picks
2014/3/13
NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and molecular diagnostic products, today announced that a study published online in the journal BMC Cancer demonstrates the analytical validity of the PAM50-based Prosigna ™ Breast Cancer Prognostic Gene Signature Assay.
Sign-up for Newly Published Analytical Validation Study Shows Precision and Reproducibility of PAM50-Based Prosigna Breast Cancer Assay in Multiple Clinical Testing Laboratories investment picks
2014/2/13
Oxygen Biotherapeutics, Inc., (“OBI”) (NASDAQ: OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced that a recently published study in the Journal of Cardiothoracic and Vascular Anesthesia provides evidence that levosimendan provides significant renal benefits to patients undergoing mitral valve surgery.
Sign-up for Newly Published Cardiac Surgery Study Provides Further Evidence that Levosimendan Significantly Improves Post-operative Kidney Function. investment picks
2013/10/1
Teva Pharmaceutical Industries Ltd.
Sign-up for Newly Published Phase III Exploratory Analysis Suggests Investigational Oral Laquinimod for Multiple Sclerosis May Reduce Brain Damage Caused by Neurodegeneration investment picks
2014/3/25
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G013688-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/3/25/11G013688/VIVUS_LOGO-396375226482.jpg MOUNTAIN VIEW, CA--(Marketwired - March 25, 2014) - VIVUS, Inc. (NASDAQ: VVUS) today announced that a review article has been published online in the Journal of Hypertension , the official publication of the International Society of Hypertension and the European Society of Hypertension, summarizing the cardiovascular benefit-risk profile of Qsymia ® (phentermine and topiramate extended-release) capsules CIV.
Sign-up for Newly Published Review Article Summarizes Cardiovascular Benefit-Risk Profile of Qsymia investment picks
2014/1/9
Coalition publishes new evidence on the patient impact of drug shortages in U.S. CHICAGO , Jan.
Sign-up for Newly Published Survey Shows Drug Shortages Still Have Major Impact on Patient Care investment picks
2014/4/3
By Benjamin Pimentel, MarketWatch SAN FRANCISCO (MarketWatch) -- Two classes of Google Inc. shares created after a 2-for-1 stock split rose sharply as they began trading Thursday.
Sign-up for Newly split Google stocks climb on Day 1 investment picks
2013/9/5
Newman Ferrara LLP is investigating potential claims against the board of directors of Astex Pharmaceuticals, Inc. (“Astex”) (Nasdaq: ASTX) concerning the proposed acquisition of Astex by Otsuka Pharmaceutical Co.
Sign-up for Newman Ferrara LLP Announces Investigation of Astex Pharmaceutics, Inc. investment picks
2013/8/14
Newman Ferrara LLP is conducting an investigation on behalf of shareholders of Blount International Inc. (“Blount”) (NYSE) (BLT) into potential violations of federal securities laws and breaches of fiduciary duty by Blount and certain of its executive officers and directors.
Sign-up for Newman Ferrara LLP Announces Investigation of Blount International Inc. investment picks
Newman Ferrara LLP has begun an investigation into potential claims against the Board of Directors of Camco Financial Corporation (“Camco”) (Nasdaq: CAFI) concerning its proposed merger agreement with Huntington Bancshares Inc. (Nasdaq: HBAN). Camco has entered into an agreement and plan of merger to be acquired by Huntington Bancshares in a cash and stock transaction valued at approximately $97 million.
Sign-up for Newman Ferrara LLP Announces Investigation of Camco Financial Corporation investment picks
2014/4/2
Newman Ferrara LLP is investigating potential claims against the board of directors of DFC Global Corp.
Sign-up for Newman Ferrara LLP Announces Investigation of DFC Global Corp. investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: NewLead Holdings Ltd. Announces Acquisition of One Newbuilding Dry Bulk Vessel to Newman Ferrara LLP Announces Investigation of DFC Global Corp.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity